Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EBIT Growth

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 60.7017.583.14-40.091,061.31

What is the latest EBIT Growth ratio of VENUS REMEDIES ?

The latest EBIT Growth ratio of VENUS REMEDIES is 60.70 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202560.70
Mar202417.58
Mar20233.14
Mar2022-40.09
Mar20211,061.31

How is EBIT Growth of VENUS REMEDIES Trending?

Years EBIT Growth % Change
Mar2025 60.7
245.28
Mar2024 17.58
459.87
Mar2023 3.14
Positive
Mar2022 -40.09
Negative
Mar2021 1061.31 -

Other Financial Ratios of VENUS REMEDIES


Compare EBIT Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹686.8 Cr -1.2% 12.7% 25.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,466.0 Cr 1.7% 2% -0.6% Stock Analytics
DIVIS LABORATORIES ₹177,298.0 Cr 0.4% -2% 37.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,538.0 Cr 6% 10.5% 13.6% Stock Analytics
CIPLA ₹127,140.0 Cr 6.8% 4.6% -0.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,500.0 Cr 4.2% 1.3% -6.7% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-1.2%

12.7%

25.8%

SENSEX

-1%

-3.2%

1.6%


You may also like the below Video Courses